nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling
|
Zhou, Li |
|
2019 |
139 |
C |
p. |
artikel |
2 |
Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation
|
Lodagekar, Anurag |
|
2019 |
139 |
C |
p. |
artikel |
3 |
Combination of cyclodextrin complexation and iontophoresis as a promising strategy for the cutaneous delivery of aluminum-chloride phthalocyanine in photodynamic therapy
|
Reis, Thaiene A. |
|
2019 |
139 |
C |
p. |
artikel |
4 |
Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study
|
Fresacher, Katja |
|
2019 |
139 |
C |
p. |
artikel |
5 |
Design, synthesis and anticancer evaluation of novel 1,3-benzodioxoles and 1,4-benzodioxines
|
Hassan, Rasha Mohamed |
|
2019 |
139 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
2019 |
139 |
C |
p. |
artikel |
7 |
Efficacy of instillation treatment with hyaluronic acid in relieving symptoms in patients with BPS/IC and uncomplicated recurrent urinary tract infections - Long-term results of a multicenter study
|
Scarneciu, Ioan |
|
2019 |
139 |
C |
p. |
artikel |
8 |
End-point modification of recombinant thrombomodulin with enhanced stability and anticoagulant activity
|
Liu, Xia |
|
2019 |
139 |
C |
p. |
artikel |
9 |
Enhanced dissolution and oral bioavailability of praziquantel by emulsification with human serum albumin followed by spray drying
|
Yamasaki, Keishi |
|
2019 |
139 |
C |
p. |
artikel |
10 |
Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption
|
Guan, Jian |
|
2019 |
139 |
C |
p. |
artikel |
11 |
Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy
|
Qu, Ying |
|
2019 |
139 |
C |
p. |
artikel |
12 |
Impact of drug particle shape on permeability and cellular uptake in the lung
|
Zellnitz, S. |
|
2019 |
139 |
C |
p. |
artikel |
13 |
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
|
Wood, Francesca L. |
|
2019 |
139 |
C |
p. |
artikel |
14 |
Pharmacokinetic profile and safety of intravenous NEPA, a fixed combination of fosnetupitant and palonosetron, in cancer patients: Prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy
|
Kurteva, Galina |
|
2019 |
139 |
C |
p. |
artikel |
15 |
Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease
|
Bagherisadeghi, Golshan |
|
2019 |
139 |
C |
p. |
artikel |
16 |
The physical stability of drugs linked to quality-by-design (QbD) and in-process technology (PAT) perspectives
|
Aucamp, Marique |
|
2019 |
139 |
C |
p. |
artikel |
17 |
TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging
|
Denora, Nunzio |
|
2019 |
139 |
C |
p. |
artikel |